Waker Bioscience at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Waker Bioscience brings 3 presentations to ESGCT 2026 in Hamburg. Its contribution is safety and characterisation analysis for edited cell products. Work includes a long-read single-cell platform that profiles editing outcomes, plus software toolkits for mapping lentiviral integration sites and for assessing small interfering RNA off-target risk.
| Organization | ESGCT 2026 Attendance |
|---|---|
Contract research organization offering cell and gene therapy services, including gene-editing outcome profiling and vector integration site analysis. | Poster Wed Oct 28 1:30pm–3:30pm A hydrogel-compartment long-read single-cell platform for comprehensive gene-editing outcome profiling in cell and gene therapy products Poster Wed Oct 28 1:30pm–3:30pm LISA-T: a comprehensive R package for lentiviral integration site analysis in gene therapy safety assessment Poster Wed Oct 28 1:30pm–3:30pm TargetSureR: A Modular R Toolkit for End-to-End siRNA Off-Target Safety Evaluation |
Instantly find 20 buyers from Waker Bioscience
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction